Status
Global HQ
Dublin, Ireland
Countries of investment
Investment stages
Industries
About
SymBiosis Capital Management is a biotechnology VC firm investing in cutting-edge biotherapeutics for serious diseases, including novel biologics and precision therapies, to revolutionize healthcare.
SymBiosis Capital Management is a biotechnology VC firm investing in cutting-edge biotherapeutics for serious diseases, including novel biologics and precision therapies, to revolutionize healthcare.
Investment Thesis
Manager's Experience
Bringing extensive expertise in early-stage investments, the fund manager has a robust portfolio spanning the technology and healthcare sectors across North America and Europe. With a strategic operator-first approach, they have successfully executed over 30 deals, demonstrating a keen ability to identify high-potential startups. Noteworthy exits include several high-growth companies that have positioned themselves as leaders in their respective fields. Their investment style emphasizes a data-driven methodology, ensuring informed decision-making throughout the investment process.